Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1

C Widmann1, N L Johnson, A M Gardner

  • 1Division of Basic Sciences, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206, USA.

Oncogene
|December 12, 1997
PubMed

Insights

Mitogen-activated protein kinase kinase kinase 1 (MEKK1) cleavage generates an active domain that induces apoptosis. This MEKK1 domain potentiates cell death when combined with stress stimuli, offering potential in anticancer therapies.

Area of Science:

  • Cellular signaling pathways
  • Apoptosis regulation
  • Molecular oncology

Background:

  • Mitogen-activated protein kinase kinases (MEKKs) are key regulators of cellular signaling cascades.
  • MEKK1, a specific MEKK, undergoes caspase-mediated cleavage to produce an active kinase domain.
  • The role of MEKK1 cleavage in apoptosis and its interaction with other signaling pathways, like Jun kinase (JNK), requires further elucidation.

Purpose of the Study:

  • To investigate the role of MEKK1 proteolytic cleavage in apoptosis induction.
  • To determine if JNK pathway activation alone is sufficient for MEKK1-mediated cell death.
  • To explore the potential of MEKK1 kinase domain expression in sensitizing cells to apoptotic stimuli.

Main Methods:

  • Site-directed mutagenesis of MEKK1 to prevent caspase cleavage.
  • Inducible acute expression of the active MEKK1 kinase domain in cells.
  • Assessment of apoptosis induction in response to MEKK1 expression and external stress agents (UV irradiation, cisplatin, TNF-alpha).

Main Results:

  • Cleavage of MEKK1 by caspases generates an active COOH-terminal kinase domain that induces apoptosis.
  • MEKK1-mediated cell death is dependent on proteolytic cleavage, not solely JNK pathway activation.
  • Acute expression of the active MEKK1 kinase domain potentiates apoptosis induced by low-dose UV, cisplatin, and TNF-alpha.

Conclusions:

  • MEKK1 proteolytic cleavage is critical for its apoptotic function.
  • MEKK1 activation can sensitize cells to various apoptotic stressors.
  • Targeting MEKK1 proteolysis and its downstream signaling presents a promising strategy for combination anticancer therapies.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...